Global Head of BD&L and Portfolio Management, Oncology
East Hanover (US)
Richard Pulik joined the Novartis Oncology Leadership Team in August 2019 as the Global Head of Business Development & Licensing (BD&L) and Portfolio Management.
In 2012, Richard joined Novartis as Senior Director Mergers & Acquisitions (M&A) in Basel and worked on the strategic analyses leading to the portfolio transactions announced in April 2014 and the subsequent execution. In 2015, he was appointed Vice President, Head of North America Investor Relations and also worked on the successful Alcon spin-off. Prior to Novartis, Richard worked at Bank of America Merrill Lynch, Monitor Group, and UBS Investment Bank and focused on M&A, strategy and healthcare.
Richard graduated from the Wharton School, University of Pennsylvania in 2001. He grew up in Slovakia, Austria and Boston, and now lives in Jersey City.